Details for 2021202979
Up to date per 01.04.2026
Actions
Details for 2021202979
Granted/Registered
European Patent
22.06.2022 A
04.09.2024 B1
27.02.2017
WO
PCT/EP2017/054489
12.05.2017
WO
PCT/EP2017/061487
A61K 31/506 20060101AFI20220509BHEP
Owner
Idorsia Pharmaceuticals LtdHegenheimermattweg 91 4123 AllschwilCH
Representative
Representative
Dr. Müllner Dipl.-Ing. Katschinka OG, PatentanwaltskanzleiWeihburggasse 91010 WienAT
Inventor
BOLLI, Martin 4123 AllschwilCH
BELLET, Marc 4123 AllschwilCH
CLOZEL, Martine 4123 AllschwilCH
IGLARZ, Marc 4123 AllschwilCH
Information about Fees